Citigroup Inc. lowered its position in Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) by 41.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 508,103 shares of the biotechnology company’s stock after selling 361,210 shares during the quarter. Citigroup Inc. owned 0.54% […]
Daniel Barchi, senior executive vice president and CIO of CommonSpirit Health, discusses the importance of focusing on core technology and infrastructure, and h
Study finds primary care providers at community health centers spend less time in EHRs than counterparts elsewhere. Factors such as team collaboration & presence of certain clinic staffers also contribute.